Dr. Vassilis L. Souliotis currently works at the Institute of Chemical Biology, National Hellenic Research Foundation, Athens, Greece. He was a Senior Researcher at the Institute of Biological Research and Biotechnology, National Hellenic Research Foundation from 2001 to 2017 and a Research Fellow at the Department of Propaedeutic Internal Medicine and Joint Rheumatology Program, Medical School, National and Kapodistrian, University of Athens since 2017. His research interests focus on the field of cellular DNA damage response (DDR) network, with a longstanding interest in the area of DNA damage formation and repair following exposure to genotoxic agents. He participated in the submission of the research proposal ELMUMY (Elucidation of risk factors and health determinants associated with the progression of Monoclonal Gammopathies to Multiple Myeloma) under Horizon Europe. HORIZON-MISS-2021-CANCER-02 call. The proposal was selected for funding by the European Commission, and he has coordinated the studies regarding molecular biology and humanized patient-derived in vivo models.